AI in Healthcare & Pharma Summit

AI in Healthcare & Pharma Summit 2026 takes place in Boston, USA, on November 17-18. Organized by RE•WORK, the summit is dedicated to empowering clinicians and helping patients by showcasing how artificial intelligence and machine learning are transforming healthcare and pharmaceutical practice. One ticket provides access to all sessions, so attendees can move between healthcare and pharma content without missing keynotes, case studies or networking.

AI in Healthcare & Pharma Summit 2026 is designed for data, analytics and AI leaders working in healthcare and life sciences, as well as clinicians and operations managers active in digital transformation.

Recommended roles include Chief Data Officers seeking strategies for AI-driven data optimization in healthcare, Chief AI Officers interested in applications in drug discovery and patient care, Heads of Analytics looking to network with pharma leaders and explore clinical trial innovations, and Data Science Directors wanting insight from real-world case studies and sponsors.

The programme highlights AI and ML methods and tools set to revolutionize healthcare, medicine and diagnostics, alongside industry applications and key insights. Core topics include speech recognition in clinical contexts, personalized medicine, diagnostics, clinical patient care, robotics, natural language processing, eHealth records and medical imaging.

The summit also surfaces themes such as digital health technology in biopharma, AI-enabled commercialization, and AI governance in regulated environments, giving participants a broad view of how intelligent systems are reshaping care and life sciences.

Across two days, the schedule combines opening and closing keynotes, innovation showcases, parallel tracks and panel discussions. Sessions feature perspectives from healthcare providers, pharma companies, technology firms and AI specialists, with talks on predictive AI for population health management, NLP and generative AI in electronic health records, computer vision in drug development, and frameworks for accelerating drug access.

The agenda also addresses building production-ready AI stacks in pharma, operationalising safe and compliant AI under global regulatory expectations, and developing AI fluency in clinical operations. Structured breaks, exhibition time and a networking drinks reception support high-quality interaction around these sessions.

Tickets are priced in USD within a published range of $449 - $2799, reflecting different packages and attendee types. Registration is handled through the official RE•WORK ticketing page, where attendees can purchase a pass that grants access to all sessions, and download the agenda or brochure to review the latest schedule and speaker information. For general enquiries, group rates, and not-for-profit or government rates, participants are invited to contact the RE•WORK team by email.

Invoice or offline payment is supported via a dedicated email workflow that collects billing, company and ticket package details, making it easier for institutional teams to confirm attendance. Prospective delegates should review the refund policy and travel arrangements on the official event website before finalizing plans.